Large Group and Small Group Markets Formulary

The information below is effective as of April 1, 2024 and applies to all commercial BCBSRI products, including all Large Group and Small Group markets. These changes do not apply to the Blue CHiP for Medicare programs. Any changes to this list are the result of a comprehensive review of relevant clinical information by the BCBSRI Pharmacy and Therapeutics Committee.

Individual Market (Direct Pay/Direct Pay Exchange) Formulary

The information below is effective as of April 1, 2024 and applies to the Individual Market segment (Direct Pay and Direct Pay Exchange) of BCBSRI products assigned to the Net Results HIM compliant formulary. These changes do not apply to the Blue CHiP for Medicare programs. Any changes to this list are the result of a comprehensive review of relevant clinical information by the Prime Therapeutics National Pharmacy and Therapeutics Committee, with consultation form the BCBSRI Pharmacy and Therapeutics Committee.